Treatment of apnea in prematurity;Traitement des apnees du premature

Archives de Pediatrie

Volumn 5, Issue 5, 1998, Pages 546-552

  Hascoet J M ^a   Boutroy, M J ^a  

^a Maternite Regionale Universitaire   (France)

Author keywords

Apnea; Doxapram; Infant, premature; Positive pressure respiration; Xanthines

Indexed keywords

CAFFEINE; CAFFEINE CITRATE; DIPHEMANIL METHYLSULFATE; DOXAPRAM; METHYLXANTHINE DERIVATIVE; THEOPHYLLINE; CENTRAL STIMULANT AGENT; XANTHINE DERIVATIVE;

AGITATION; APNEA; ARTICLE; EXCITABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; TACHYCARDIA; INTERMITTENT POSITIVE PRESSURE VENTILATION; MONITORING; NEWBORN;

APNEA; CENTRAL NERVOUS SYSTEM STIMULANTS; DOXAPRAM; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTERMITTENT POSITIVE-PRESSURE VENTILATION; MONITORING, PHYSIOLOGIC; XANTHINES;

EID: 0032080405     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(99)80321-2     Document Type: Article

References (15)

1. es Journées nationales de néonatalogie. Paris: Éditions Karger; 1996. p 33-42
2. es Journées nationales de néonatalogie. Paris: Éditions Karger; 1996. p 43-51
3. 3 Hascoët JM, Parker RA, Lindstrom DP, Hodges PJ, Law AB, Cotton RB. Short apnea status in the thriving preterm newborn: effect on cerebral circulation. Pediatr Res 1989; 25: 1288A
4. es Journées nationales de néonatalogie. Paris: Éditions Karger; 1996. p 52-65
5. 5 Aranda J, Gorman W, Bergsteinsson H, Gunn T. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 1977; 90: 467-72
6. 6 Bairam A, Boutroy MJ, Badonnel Y, Vert P. Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in preterm infant. J Pediatr 1987; 110: 636-9
7. 7 Stephenson T. Caffeine for Neonates. Paediatr Perinat Drug Ther 1997; 1: 46-9
8. 8 Bairam A, Boutroy MJ, Vert P. Un stimulant respiratoire, le doxapram et ses applications en pédiatrie. Arch Fr Pédiatr 1992; 49: 469-74
9. 9 Boutroy MJ, Dalati M, Barbé F, Hascoët JM, Doxapram per os: an alternative to IV infusion in treating apnea of prematurity? Pediatr Res 1994; 35: 82A
10. 10 Lupoglazoff JM, Bedu A, Faure C, Denjoy I, Casasoprana A, Cézard JP et al. Allongement de l'espace QT sous cisapride chez le nouveau-né et le nourrisson. Arch Pédiatr 1997; 4: 509-14
11. 11 Agence du médicament, direction de l'évaluation. Information des prescripteurs sur l'utilisation du Prantal®. Arch Pédiatr 1997; 4: 78-80
12. 12 Moriette G, Apnées du nouveau-né. In: Relier JP, Laugier J, Salle BL, éds. Médecine périnatale. Paris: Flammarion Médecine-Sciences; 1990. p 329-34
13. es Journées nationales de néonatalogie, Paris: Éditions Karger; 1996. p 13-27
14. es Journées nationales de néonatalogie. Paris: Éditions Karger; 1996. p 110-8
15. 15 Moa G, Nilsson K. Nasal continuous positive airway pressure: experiences with a new technical approach. Acta Paediatr 1993; 82: 210-1